A research study in Uganda to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illness

Not Applicable

Completed

• Conditions: Mental, neurological and substance misuse disorders, which includes severe mental illness (psychosis, severe depression and anxiety), epilepsy and comorbid substance misuse; Mental and Behavioural Disorders

• Registration Number: ISRCTN25146122
• Lead Sponsor: Queen Mary University of London

Brief Summary

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31200671/ (added 11/08/2022) 2024 Results article in https://doi.org/10.4102/sajpsychiatry.v30i0.2138 (added 07/02/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-20
• Study Completion: 2020-06-25
• Last Update Posted: 19 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 182

Inclusion Criteria

1. Primary diagnosis of severe mental illness (psychosis, bipolar disorder, psychotic/severe depression), epilepsy and/or co-morbid substance misuse, assessed by the ICD-10
2. Attending the outpatient clinic at Butabika, or surrounding clinics in Kampala for at least six months
3. Live within a 20km radius of Kampala city/or the clinic where recruitment will take place
4. Aged 18-65 years old
5. Capacity to provide informed consent assessed by UBACC Score of =14 after a maximum of 3 attempts
6. Scores 5 or below on the MANSA scale
7. Able to communicate in Luganda or English

Exclusion Criteria

1. Primary diagnosis of substance-use disorder; organic psychosis and/or neurocognitive disorder
2. Currently an inpatient at the time of recruitment
3. Already participating in the DIALOG+ study at another clinic or another study organised by this research group
4. Participating in another interventional study taking place at Butabika hospital

Study & Design

• Study Type: Interventional
• Study Design: Not specified